銀邦股份(300337.SZ):飛而康快速控股股東變更為產業集團
格隆匯12月30日丨銀邦股份(300337.SZ)公佈,公司於2019年12月5日召開第三屆董事會第二十一次會議、第三屆監事會第十六次會議審議通過《關於轉讓參股公司股權暨關聯交易的議案》,公司擬以人民幣約1.26億元向關聯方無錫產業發展集團有限公司(“產業集團”)轉讓公司持有的飛而康快速製造科技有限責任公司(“飛而康快速”)22.85%的股權,對應飛而康快速註冊資本為人民幣5405.40萬元。
公司於2019年12月30日接到飛而康快速通知,飛而康快速已完成相關變更工商登記手續,飛而康快速控股股東由無錫安迪利捷貿易有限公司變更為產業集團,並取得了無錫市新吳區市場監督管理局核發的《營業執照》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.